key: cord-0899166-uzru1lvo
authors: Brugnara, Carlo
title: The Erythrocyte, a Novel Disease-Mediator for COVID-19 Vasculopathy?
date: 2022-03-28
journal: JACC Basic Transl Sci
DOI: 10.1016/j.jacbts.2022.01.012
sha: 3bac7b4d982f2672800aefc30400358439f8eb6e
doc_id: 899166
cord_uid: uzru1lvo

[Figure: see text]

is that all patients were on various levels of oxygen therapy, which makes it impossible to discern COVID-19Àspecific alteration versus oxygen-induced alteration of the red cell membrane and function. It is known that oxygen therapy promotes oxidation of membrane lipids, as shown by increased hydroperoxide values in the erythrocyte membrane of preterm infants exposed to oxygen therapy, 4 and that erythrocyte viscosity and aggregation are increased in patients with COVID-19 who require oxygen supplementation. 5 The changes in erythrocyte viscosity and aggregation are largely mediated by increased fibrinogen, suggesting that they may be secondary to hypercoagulability and vascular changes associated with pulmonary lesions. 5 Studies in patients with type 1 diabetes mellitus and who were exposed to hyperbaric oxygen showed decreased iNOS activity and/or expression in lymphocytes and increased plasma arginase activity, 6 which suggested that a NO-restricted state could be a consequence of oxygen therapy.

In conclusion, this is a well done and provocative study, which suggests the need for additional indepth mechanistic studies to determine the role of erythrocyte abnormalities in the vasculopathy associated with COVID-19.

The author has reported that he has no relationships relevant to the contents of this paper to disclose. 

Pathophysiology of sickle cell disease

Erythrocytes induce vascular dysfunction in COVID-19

Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns

Increased blood viscosity and red blood cell aggregation in patients with COVID-19

Early effects of hyperbaric oxygen on inducible nitric oxide synthase activity/expression in lymphocytes of type 1 diabetes patients: a prospective pilot study